:Primidolol

{{Chembox

| ImageFile = primidolol.svg

| ImageAlt =

| IUPACName = 1-[2-[[2-Hydroxy-3-(2-methylphenoxy)propyl]amino]ethyl]-5-methylpyrimidine-2,4-dione

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 67227-55-8

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 56QH73D78K

| PubChem = 68563

| InChI = 1S/C17H23N3O4/c1-12-5-3-4-6-15(12)24-11-14(21)9-18-7-8-20-10-13(2)16(22)19-17(20)23/h3-6,10,14,18,21H,7-9,11H2,1-2H3,(H,19,22,23)

| InChIKey = RETPFDTUCPKFEC-UHFFFAOYSA-N

| SMILES = CC1=CC=CC=C1OCC(CNCCN2C=C(C(=O)NC2=O)C)O

| ChemSpiderID = 61835

| KEGG = C11774

}}

|Section2={{Chembox Properties

| C=17 | H=23 | N=3 | O=4

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility =

}}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt =

}}

}}

Primidolol is a beta adrenergic receptor antagonist.{{cite journal|pmid=6104564|year=1980|last1=Saltvedt|first1=E|last2=Fauchald|first2=P|title=Effect of single and twice daily doses of primidolol (UK-11,443) in hypertension|volume=6|issue=8|pages=528–33|doi=10.1185/03007998009109482|journal=Current Medical Research and Opinion}}{{cite journal|pmid=4147835|year=1973|last1=Augstein|first1=J.|last2=Cox|first2=D. A.|last3=Ham|first3=A. L.|last4=Leeming|first4=P. R.|last5=Snarey|first5=M.|title=Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols|journal=Journal of Medicinal Chemistry|volume=16|issue=11|pages=1245–1251|doi=10.1021/jm00269a007}}{{Cite patent|country=DE|number=2238504|pubdate=1973-02-22|title=Propanolaminderivate [Propanolamine derivates]|assign=Pfizer Corp.|inventor1-last=Augstein|inventor1-first=Joachim|inventor2-last=Cox|inventor2-first=David Alexander|inventor3-last=Ham|inventor3-first=Allan Leslie}}